LOQTORZI vs MYSOLINE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 7, 2026·How we rate

Possible drug interaction. LOQTORZI and MYSOLINE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	LOQTORZI	MYSOLINE
Rating	New	74/100
Pharmacy pays	—	~$2.89 /30
Type	RX	RX
Active ingredient	TORIPALIMAB-TPZI	PRIMIDONE
Manufacturer	Coherus Biosciences Inc	Valeant Pharm Intl
Dosage forms	Injectable	Tablet
Drug class	—	Anti-Epileptic Agent
Boxed warning	None	None
Treats	Nasopharyngeal Carcinoma	Partial Epilepsies, Tonic-Clonic Epilepsy, Tremor

loqtorzi mysoline

Rating

New

74/100

Pharmacy pays

—

~$2.89 /30

Type

Active ingredient

TORIPALIMAB-TPZI

PRIMIDONE

Manufacturer

Coherus Biosciences Inc

Valeant Pharm Intl

Dosage forms

Injectable

Tablet

Drug class

—

Anti-Epileptic Agent

Boxed warning

None

Treats

Nasopharyngeal Carcinoma

Partial Epilepsies, Tonic-Clonic Epilepsy, Tremor

Frequently asked questions

What is the difference between Loqtorzi and Mysoline?

Loqtorzi contains Toripalimab-Tpzi, while Mysoline contains Primidone — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.